AstraZeneca's sales increase strongly in 2001

Published: 2-Mar-2002


AstraZeneca sales grew strongly last year to US$16.5bn (€18.81bn), up 8% on the previous year, thanks to a good performance in the first and fourth quarters. Operating profit was 6% higher at $4.16bn (€4.74bn). Sales to Japan rose particularly sharply: up 16% to $851m (€970m).

With the exception of the gastro-intestinal sector, all therapeutic areas registered significant increases, accelerating particularly in the second half of the year. Although GI sales rose by only 2% worldwide, Nexium sales grew steadily in European markets and went up by an overall 10% outside the US. Cardiovascular sales were 6% higher at $3.54bn (€4.03bn), up 8% in the US and 4% in the rest of the world, with sharp rises in particular for Atacand and Seloken/Toprol-XL.

Sales of respiratory drugs were 17% higher at $1.56bn (€1.78bn), boosted by strong performances from Plumicort and Symbicort. In particular Symbicort has taken off rapidly in Europe and now enjoys almost 20% share of the fixed combination market in the 13 countries where it has been launched. Oncology sales rose by 16% to $2.15bn (€2.45bn) and CNS by 48% to $999m (€1.14bn).

According to ceo Tom McKillop, the company is reshaping its portfolio with the aim of replacing sales that may be lost to generic competition in the near future. 'The transformation will be largely complete by the end of 2003,' he said. 'The real fruits of our efforts will show in 2004.'

See more

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

Read more
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Subscribe now